ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Myogen

Myogen (MYOG)

0.00
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

MYOG Latest News

Gilead Sciences Completes Acquisition of Myogen

Gilead Sciences, Inc. (Nasdaq:GILD) announced today that it has completed its acquisition of Myogen, Inc. (Nasdaq:MYOG). On November 17, 2006, Gilead caused one of its...

Darusentan Data to Be Presented at AHA 2006 -- Chicago

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Darusentan Data to Be Presented at ISH 2006 -- Fukuoka, Japan

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Four Ambrisentan Studies to Be Presented at Chest 2006 -- Salt Lake City

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of...

Seven Summits Research Releases Comments on GOOG, ABX, HET, CBS, and MYOG

CHICAGO, Oct. 2 /PRNewswire/ -- Seven Summits Research Releases NewsBites on key stocks. Seven Summits Strategic Investments NewsBites are available to all investors at...

Gilead Sciences to Acquire Myogen, Inc. for $2.5 Billion

Gilead Sciences, Inc. (Nasdaq:GILD) and Myogen, Inc. (Nasdaq:MYOG) announced today that the companies have signed a definitive agreement under which Gilead plans to acquire...

Myogen to Present at the UBS Global Life Sciences Conference

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

Myogen Initiates Open-Label Phase 3 Clinical Trial of Ambrisentan in Patients with Pulmonary Hypertension

Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

The American Lung Association and Myogen Announce Pulmonary Arterial Hypertension Educational Partnership

The American Lung Association and Myogen, Inc. (Nasdaq: MYOG) today announced that they will collaborate on a new public awareness initiative to educate the public about pulmonary...

Myogen Reports 2006 Second Quarter Results

Myogen, Inc. (Nasdaq:MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 1.42
(145.25%)
174.6M
TGLTreasure Global Inc
$ 1.13
(66.10%)
135.54M
LASELaser Photonics Corporation
$ 16.815
(61.53%)
10.37M
NVVENuvve Holding Corporation
$ 6.03
(53.83%)
29.86M
UXINUxin Ltd
$ 2.368
(49.40%)
16.88M
ELABElevai Labs Inc
$ 0.1033
(-63.11%)
20.37M
ADNAdvent Technologies Holdings Inc
$ 2.21
(-29.62%)
45.59k
BNZIBanzai International Inc
$ 4.05
(-28.82%)
1.41M
ADTXAditxt Inc
$ 0.2749
(-28.15%)
2.61M
ZJYLJin Medical International Ltd
$ 2.96
(-27.45%)
802.89k
XPONExpion360 Inc
$ 0.105
(23.82%)
393.05M
KAVLKaival Brands Innovations Group Inc
$ 1.42
(145.25%)
174.6M
NVDANVIDIA Corporation
$ 116.22
(0.19%)
155.42M
INTCIntel Corporation
$ 22.57
(3.34%)
149.8M
TGLTreasure Global Inc
$ 1.13
(66.10%)
135.54M

Your Recent History

Delayed Upgrade Clock